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ABSTRACT 
Background: Daily activity is a potentially important 
measure for assessing prognosis in individuals with 
chronic heart failure (CHF), and few studies have 
investigated the prognostic value of daily activity 
measurement. The present study sought to determine 
whether there is an association between daily activity 
and mortality/mean life expectancy as predicted by 
the Seattle Heart Failure Model (SHFM), and to pro- 
vide an estimate of the anchor-based minimum clini- 
cally important difference (MCID) for daily activity 
measured by single-axis accelerometers in implanted 
cardiac defibrillators. Methods: This study utilized a 
retrospective chart review of 102 medical records of 
patients with CHF and Medtronic® implanted car- 
diac defibrillators (ICDs). Mean daily activity was 
calculated for a two week period prior to both a base- 
line and follow-up routine clinical visit. Clinical cha- 
racteristics from the baseline clinic visit were used for 
calculating SHFM estimates of mean life expectancy, 
1-year mortality, and 5-year mortality. A five-point 
global rating scale was scored based on documented 
clinician impression, patient self-report, and labora- 
tory and cardiographic tests for determining the 
MCID. Results: There was a moderate correlation be- 
tween baseline daily activity and each of the SHFM 
prognostic indicators: 1-year mortality (r = 0.36, p < 
0.001, 5-year mortality (r = 0.40, p < 0.001), and life 
expectancy (r = 0.43, p < 0.001). The MCID for a de- 
cline in daily activity was approximately 0.5 hours 
and was approximately 1.0 hours for improvement in 
daily activity. Conclusions: Although previous re- 
search has established the short-term predictive value 
of ICD-measured daily activity for CHF-related cli- 
nical events, no prior study has examined the longer- 
term prognostic value of ICD-based daily activity. 
The results of the present study suggest that low daily 
activity, as recorded by ICDs in patients with CHF, 
should prompt a more formal evaluation of prognosis 
using the SHFM. Furthermore, changes of 0.5 to 1.0 
hours of activity per day appear to be clinically mean- 
ingful. 
 
Keywords: Heart Failure; Daily Activity; Prognosis;  
Cardiac Defibrillator 
1. INTRODUCTION 
Individuals with chronic heart failure (CHF) are charac-
terized by reduced daily physical activity, which is be- 
lieved to contribute to a cycle of inactivity and decondi- 
tioning [1-9] and to reductions in exercise tolerance fol- 
lowing the cessation of an exercise program [10,11]. Al- 
though daily activity has been used as an endpoint in 
several intervention-based studies [7,10-14], little data 
exists about the prognostic value of daily activity in heart 
failure. Walsh et al. [15] found that daily activity, mea- 
sured using a pedometer dichotomized at 250 × 102 steps 
per week, was an independent predictor of mortality in a 
multivariate analysis of 84 subjects with CHF. More re-
cently (2010), in a sample of 60 subjects with CHF, 
Howell et al. [16] reported that subjects with a peak daily 
activity level of less than 22 metabolic equivalents per 
minute (measured using actigraphy) had lower 11-month, 
event-free survival. The devices used to measure daily 
activity in the aforementioned studies, however, are ex- 
ternal devices that depend on subjects’ adherence, and 
neither study provided data regarding the amount of 
change in daily activity that is considered to be clinically 
meaningful. The single-axis accelerometers in implanted 
cardiac defibrillators (ICDs) avoid the potential problems *Corresponding author. 
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of subject non-adherence and selection bias in studies 
examining daily activity in patients with CHF. No prior 
study has investigated whether this implanted device- 
based measure of daily activity is associated with life 
expectancy and mortality, nor has any prior study inves- 
tigated what amount of change in this measure is consi- 
dered to be clinically meaningful. These are the primary 
aims of the present study. 
Medtronic® ICDs (Medtronic, Minneapolis, MN) con- 
tain a single-axis accelerometer that, on a minute-to- 
minute basis, determines whether patient activity ex- 
ceeded an equivalent of 70 - 80 steps/minute. The device 
then records the number of minutes of activity on a daily 
basis, which is stored for a rolling 14 month period [17]. 
Among the various methods for measuring daily activity, 
including questionnaires, measurement of energy expen- 
diture, and external accelerometers [18], ICD-based daily 
activity measures are not limited by short monitoring 
periods, monitor wearing non-adherence, and patient re- 
collection. Despite these advantages, few studies have 
utilized this measure [19-21]. 
The daily activity data recorded by Medtronic® im- 
planted ICDs (labeled “patient activity” by Medtronic®) 
have been examined in three studies. Gulati et al. [19] 
found that the six-minute walk test (6MWT) and daily 
activity measured within the preceding or subsequent 24 
hours of conducting the test were moderately correlated 
(r = 0.42 and 0.49, respectively). Despite their findings 
of only moderate correlation, the authors concluded that 
daily activity may be considered a surrogate for the 6 
MWT. Both Adamson et al. [20] and Small et al. [21] 
considered daily activity among a variety of device- 
based parameters for predicting hospitalization for acute 
decompensated heart failure. Only Adamson et al. [20] 
found that a decline in daily activity was a statistically 
significant predictor, with a decline of 0.4 hours per day 
in activity between baseline and time of hospitalization. 
Daily activity may not have been a significant predictor 
in the analysis by Small et al. [21] because they di-
chotomized daily activity at 0.5 hours per day. No prior 
study has investigated the amount of change in ICD- 
measured daily activity that is considered to be clinically 
meaningful. 
The minimum clinically important difference (MCID) 
is the smallest change that a patient would perceive as 
beneficial, and when considering a decline in the mea- 
sure of interest, would indicate the need for a change in 
treatment [22,23]. Calculation of the MCID includes dis- 
tribution-based and anchor-based methods [23]. Distri- 
bution-based methods include calculation of an effect 
size which provides a ratio of change in an outcome to 
the baseline standard deviation of that measure for inter- 
preting whether the effect observed in a given trial was 
statistically significant, while anchor-based methods de- 
termine the mean amount of change associated with per- 
ceived level of change using the Global Rating of Change 
Scale (GRS). The anchor-based MCID can utilize either 
a patient-based or clinician-based anchor [25]. A clini- 
cian-based anchor in addition to other objective clinical 
data may be more appropriate for judging change in dis-
ease status [24]. 
The only two studies to report on the relationships 
between daily activity and prognosis in individuals with 
CHF were longitudinal studies that measured mortality 
directly [15,16]. Howell et al. [16] followed subjects for 
up to one year and Walsh et al. [15] up to five years. Al- 
though direct measurement of mortality is ideal, it is dif- 
ficult to study design to implement. The Seattle Heart 
Failure Model (SHFM) is a multivariate risk model de- 
veloped based on data from six published pharmacologic 
intervention clinical trials representing nearly 11,000 
patients with systolic heart failure [24]. The model pre- 
dicts four primary outcomes: 1, 3, and 5-year mortality 
and mean life expectancy. The 16 independent predictors 
in the model include data related to patient characteris- 
tics, medications, laboratory results, and use of im- 
planted interventional devices. No prior study has exam- 
ined whether daily activity is associated with the SHFM 
prognostic indicators. 
In summary, daily activity is a potentially important 
measure for assessing prognosis in individuals with CHF. 
Further, it is not known whether daily activity is associ- 
ated with the SHFM prognostic estimates and what 
amount of change in daily activity is necessary to be 
considered clinically meaningful. Therefore, the purpose 
of the present study was two-fold: 1) To determine whe- 
ther there is an association between daily activity and 
mortality/mean life expectancy as predicted by the Seat- 
tle Heart Failure Model, and 2) to provide an estimate of 
the anchor-based MCID for daily activity measured by 
single-axis accelerometers in implanted devices. 
2. METHODS 
2.1. Design 
Retrospective chart review of clinical data at two time 
points at least three months apart between January 2008 
and January 2011 in patients with Medtronic® ICDs. 
2.2. Subjects 
One hundred thirty-five medical records (approximately 
two-thirds of available records) were randomly selected 
from a list of patients with Medtronic® ICDs who were 
managed by a tertiary heart failure and transplant ser- 
vices clinic between January 2008 and January 2011. 
Medical records were included if the patient had a 
Medtronic implanted device (ICD or biventricular ICD) 
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and a diagnosis of systolic heart failure with a history of 
LVEF < 40%. Records were excluded if there was 
insufficient data in the medical record to achieve the 
study objectives described below. 
2.3. Clinical Data Extraction 
Clinical data representing two points in time for each 
patient were extracted. Time point 1 was a clinic visit for 
which daily activity data was available for the preceding 
two weeks and that provided the necessary clinical and 
laboratory data for the SHFM. Time point 2 was a sub- 
sequent clinic visit at least three months after time point 
1 for which daily activity data was available in the pre- 
ceding two weeks and had sufficient documentation for 
determining whether or not there was a change in clinical 
status. Extracted data included the variables required for 
the SHFM, patient and clinician quotes regarding change 
in clinical status between the two time points, and de- 
vice-recorded daily activity. 
2.4. Measurements 
The anchor used to calculate the MCID was the 5-point 
GRS. The GRS captured change in clinical status using 
the clinician’s documented impression of the course of 
the patient’s overall disease state as supported by docu- 
mented patient self-report and changes in the patient’s 
clinical characteristics. These clinical characteristics in- 
cluded left ventricular ejection fraction, New York Heart 
Association (NYHA) Functional Class, B-type natri- 
uretic peptide, hospitalization or other significant health 
event, and change in CHF-related medications. 
Medtronic® ICDs contain a single-axis accelerometer 
that record the amount of daily activity every 24 hours 
for a rolling 14-month period. The number of hours of 
activity in each 24 hour period is based on the number of 
minutes per day in which the patient was active at or 
above an equivalent of 70 - 80 steps/min, with each min- 
ute recorded as a dichotomized value of yes/no [17]. 
Daily activity is plotted for a 14-month period on the 
printed report generated by the Cardiac Compass® de- 
vice summary. The data point included for analysis was a 
visual estimate of the mean activity (hours per day) for 
the 2 weeks preceding the clinic visit on which the time 
point is based. Daily activity data were not measured/ 
extracted until after other data, including the GRS, were 
collected. To ensure accuracy of visually estimating the 
mean daily activity from the activity graph, two re- 
searchers independently estimated the mean daily acti- 
vity for 25 separate sample cases with a range of 0 to 8 
hours of activity per day. The intra-class correlation co- 
efficient (2,1) was 0.998 (95% confidence interval 0.996 
to 0.999). 
The SHFM prognostic estimates for life expectancy, 
1-year mortality, and 5-year mortality were calculated 
using the extracted clinical data from time point 1. Three 
laboratory values not routinely collected on each clinical 
visit that are required for the SHFM were total choles- 
terol, lymphocyte percentage, and uric acid. Therefore, if 
the lab value was collected within six months of the cli- 
nic visit, this value was recorded and attributed to the 
baseline dataset. Using this strategy, total cholesterol and 
uric acid were missing in 4 and 42 cases, respectively. 
These values were imputed using the aregImpute multi- 
ple imputation function from Harrell’s Hmisc package 
[26] as used by Gorodeski et al. [27] who were missing 
similar data for use in the SHFM. 
2.5. Data Analysis 
2.5.1. Association between Daily Activity and  
Mortality/Life Expectancy 
The Pearson correlation coefficient was calculated for 
daily activity at time point 1 (hours per day) and each of 
the following predicted values derived from the SHFM: 
1 year mortality (%), 5 year mortality (%), and mean life 
expectancy (years). 
2.5.2. Determination of the Anchor-Based MCID 
Change in daily activity between time points 1 and 2 was 
used to determine the anchor-based MCID for this mea- 
sure. One-way analysis of variance with repeated planned 
contrasts was used to compare the mean change in daily 
activity for each category of the GRS to the previous one. 
The mean and 95% confidence interval for change in 
daily activity between time points 1 and 2 for each level 
of the GRS were used to identify whether there was an 
apparent threshold of change in daily activity for those 
with and without change in clinical status. The magni- 
tude of the MCID was contextualized using the NYHA 
Functional Classification. Classes II and III/ IV represent 
distinct symptomatic clinical presentations and have pre-
viously been shown to have statistically significantly 
different aerobic capacities [28], and the difference in 
daily activity between these classes may provide insight 
into what amount of change in daily activity is clinically 
meaningful. Therefore, daily activity for Classes II and 
III/IV were compared using t-tests. 
3. RESULTS 
Of the 135 medical records reviewed, 33 records were 
excluded due to not having at least two clinic visits and/ 
or not having a Cardiac Compass® report available for 
extracting daily activity data. Descriptive statistics for 
the overall sample of 102 included cases are presented in 
Table 1. There was a moderate correlation between base- 
line daily activity and each of the SHFM prognostic in- 
dicators: 1-year mortality (r = 0.36, p < 0.001, 5-year  
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Table 1. Descriptive statistics. 
 Mean (SD) 
Age 64.6 (13.3) years 
Gender 30 females, 72 males 
Etiology 50 ischemic, 52 nonischemic 
NYHA-FC 2.0 (0.76) 
LVEF 27.8 (11.5)% 
Type of Device 26 ICD, 72 BiVICD 
Time between Visits 7.5 (4.2) months 
Daily Activity 2.6 (1.7) hours·day–1 
Life Expectancy 10.1 (5.2) years 
1 Year Mortality 9.4 (9.3)% 
5 Year Mortality 33.0 (24.1)% 
NYHA-FC = New York Heart Association Functional Class; LVEF = left 
ventricular ejection fraction; ICD = implantable cardiac defibrillator; BiVICD = 
biventricular implantable cardiac defibrillator. 
 
mortality (r = 0.40, p < 0.001), and life expectancy (r = 
0.43, p < 0.001). Figure 1 depicts the scatterplot for 
daily activity and life expectancy. 
With regard to the MCID for ICD-measured daily ac- 
tivity, descriptive statistics for cases stratified by GRS 
are presented in Table 2. There was a statistically sig- 
nificant main effect of GRS on change in daily activity 
[F(4,97) = 21.48, p = 0.000, ω = 0.41]. Planned contrasts 
revealed statistically significant differences (p < 0.05) 
between each subsequent GRS category except between 
“about the same” and “a little better” (p = 0.085). Figure 
2 demonstrates the mean and 95% confidence interval 
for change in daily activity for each GRS category. The 
MCID for a decline in daily activity is approximately 0.5 
hours and is approximately 1.0 hours for improvement in 
daily activity. There was a statistically significant mean 
difference of 0.88 hours of baseline activity between 
NYHA classes II and II/IV [2.7 (1.8) hours for those with 
NYHA class II versus 1.8 (1.5) hours for those with class 
III/IV, t(1,73) = 2.24, p = 0.014, effect size = 0.54]. 
4. DISCUSSION 
Daily activity is a potentially important measure of pro- 
gnosis in individuals with CHF, and no prior published 
study has reported what amount of change in daily activ- 
ity is considered to be clinically meaningful. The results 
of the present study demonstrated that ICD-measured 
daily activity was associated with disease severity as 
measured by the SHFM, and changes of 0.5 and 1.0 
hours of daily activity appear to represent clinically 
meaningful decline and improvement, respectively. 
With regard to the moderate correlation between daily 
activity and the SHFM, daily activity was more strongly 
associated with life expectancy than 1- and 5-year mor- 
tality, explaining 19% of the variance in calculated life  
 
Figure 1. Scatterplot of baseline daily activity versus life ex-
pectancy. r = 0.43, p < 0.001. 
 
expectancy. Implanted device-measured daily activity 
has previously been demonstrated to be a useful predic- 
tor of hospitalization for acute decompensated heart fail- 
ure [20], and daily activity measured using actigraphy 
and pedometers was predictive of mortality [15,16]. The 
results of the present study suggest that, in addition to 
consideration of other prognostic factors including the 
SHFM, ICD-based measurement of daily activity may 
also be clinically useful in identifying individuals with 
increased risk of mortality and decreased life expectancy. 
This research did not address whether an intervention to 
improve daily activity would result in a change in pro- 
gnosis, and this should be addressed by future research. 
With regard to the MCID for daily activity, a lesser 
amount of change in daily activity was associated with a 
clinically meaningful decline compared to the amount of 
change representing clinically meaningful improvement. 
There are two potential explanations for this difference. 
First, although not previously reported for daily activity, 
two prior studies [29,30] found that the MCID for im- 
provement and decline in the 6MWT in individuals with 
CHF were dissimilar. Second, and perhaps more likely, 
there was no statistically significant difference in daily 
activity between those cases rated as “about the same” 
and “a little better” because this analysis had less statis- 
tical power (effect size = 0.43, 1 – β = 0.38) than did the 
analysis of those cases rated as “about the same” and “a 
little worse” (effect size = 0.55, 1 – β = 0.55) due to a 
smaller mean difference. 
There are two considerations for contextualizing the 
magnitude of these MCID estimates. First, Small et al. 
[21] found a mean decline of 0.4 hours in those patients 
hospitalized for acute decompensated heart failure, 
which likely represents a clinically meaningful change 
and is consistent with the results of the present study. 
Additionally, the mean difference of 0.88 hours in the 
present study between those with NYHA class II and 
class III/IV, although not suggestive of a direction of 
change (e.g., improvement vs. decline), also suggests 
that a meaningful difference in daily activity is ≤1.0 
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Table 2. Descriptive statistics stratified by global rating scale category. 
 
Much Worse 
n = 10 
Mean (SD) 
A Little Worse 
n = 13 
Mean (SD) 
About the Same 
n = 57 
Mean (SD) 
A Little Better 
n = 12 
Mean (SD) 
Much Better 
n = 10 
Mean (SD) 
Age [years] 69.8 (7.4) 62.3 (17.0) 64.8 (12.4) 64.4 (18.4) 62.0 (11.4) 
Gender [% male] 90.0 61.5 71.9 66.7 60.0 
Etiology [% ischemic] 50.0 69.2 49.1 25.0 50.0 
LVEF [%] 26.5 (10.6) 24.5 (5.3) 31.0 (12.4)* 26.3 (9.3) 17.5 (8.9)* 
NYHA-FC 2.0 (0.8) 1.8 (0.6) 1.9 (0.8) 2.2 (0.7) 2.9 (0.7) 
Baseline Activity 
[hours·day–1] 2.6 (2.2) 2.9 (1.5) 2.7 (1.6) 2.7 (2.4) 1.9 (1.8) 
Change in Activity 
[hours·day–1] –1.3 (0.7) –0.52 (0.7)* 0.04 (0.6)* 0.4 (0.6) 1.08 (0.7)* 
*one-way ANOVA repeated contrast p < 0.05 compared to previous level; LVEF = left ventricular ejection fraction, NYHA-FC = New York Heart Association 
Functional Class. 
 
 
Units for change in daily activity are hours per day 
Figure 2. Mean and 95% confidence interval for change in daily activity stratified by global 
rating scale. 
 
hours. Other indices of clinically meaningful change for 
ICD-measured daily activity should be examined in fu- 
ture research. For example, the minimum detectable dif-
ference (an index of test-retest reliability or measure- 
ment error), would provide an estimate of the amount of 
variation in daily activity that represents background 
“noise,” against which changes in daily activity could be 
compared. 
4.1. Limitations 
There are several limitations of the present analyses. 
First, the anchor used for the MCID analysis was based 
on clinician impression as abstracted from clinical docu- 
mentation, which was not intended for such an analysis. 
However, clinician-based anchors have been reported by 
some to represent a better anchor than patient percep- 
tion-based anchors [25]. The present study used the cli-
nician’s impression of change in clinical status as sup- 
ported by a wide range of supporting clinical data. Sec- 
ond, uric acid had to be imputed in 42 cases, nearly one 
third of the overall data set. However, the method used 
for imputation has been previously demonstrated for in a 
greater percent of cases for this variable for use in the 
SHFM [27]. Third, the findings of the present paper may 
not be generalizable to other types and brands of cardiac 
defibrillators as the measurement, processing, and re- 
porting of activity data by other devices may be substan- 
tially different than Medtronic® devices. Fourth, not all 
patient characteristics were similar when stratified ac- 
cording to the GRS. For example, there was a greater 
proportion of males in the “much worse” group and a 
lower mean LVEF in the “much better” group. The in- 
fluence of the differences on the results is not clear. Fi- 
nally, daily activity was measured using a visual esti- 
mate from a printed graph using a two-week sample pre- 
ceding each clinical visit. Although this method demon- 
strated excellent inter-rater reliability, a more accurate 
method for quantifying daily activity is needed. Addi- 
tionally, use of longer sampling frame that allows for 
characterization of the trend of daily activity (i.e., im- 
proving, declining, fluctuating, or stable) prior to calcu- 
lation of the SHFM prognostic indicators may reveal a 
greater prognostic value for daily activity.  
4.2. Conclusion 
Daily activity as recorded by ICDs in patients with CHF 
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appears to be a promising new measure for the research 
and clinical settings. Low daily activity, as recorded by 
ICDs in patients with CHF, should prompt a more formal 
evaluation of prognosis using the SHFM. Furthermore, 
changes of 0.5 to 1.0 hours of activity per day appear to 
be clinically meaningful.  
5. ACKNOWLEDGEMENTS 
The authors thank the clinical staff at the Spectrum Health Cardiac 
Device Clinic. 
REFERENCES 
[1] Oka, R.K., Gortner, S.R., Stotts, N.A. and Haskell, W.L. 
(1996) Predictors of physical activity with chronic heart 
failure secondary to either ischemic or idiopathic dilated 
cardiomyopathy. American Journal of Cardiology, 77, 
159-163. doi:10.1016/S0002-9149(96)90588-3 
[2] Van den Berg-Emons, H., Bussmann, J., Balk, A., et al. 
(2001) Level of activities associated with mobility during 
everyday life in patients with chronic congestive heart 
failure as measured with an “Activity Monitor.” Physical 
Therapy, 81, 1502-1511. 
[3] Davies, S.W., Jordan, S.L. and Lipkin, D.P. (1992) Use of 
limb movement sensors as indicators of the level of eve-
ryday physical activity in chronic congestive heart failure. 
American Journal of Cardiology, 69, 1581-1586. 
doi:10.1016/0002-9149(92)90707-6 
[4] Hoodless, D.J., Stainer, K., Savic, N., et al. (1994) Re-
duced customary activity in chronic heart failure: As-
sessment with a new shoe-mounted pedometer. Internati- 
onal Journal of Cardiology, 43, 39-42. 
doi:10.1016/0167-5273(94)90088-4 
[5] Walsh, J.T., Andrews, R., Evans, A. and Cowley, A.J. 
(1995) Failure of “effective” treatment for heart failure to 
improve customary activity. British Heart Journal, 70, 
373-376. doi:10.1136/hrt.74.4.373 
[6] Toth, M.J., Gottlieb, S.S., Goran, M.I., et al. (1997) Daily 
energy expenditure in free-living heart failure patients. 
American Journal of Physiology, 272, E469-E475. 
[7] van den Berg-Emons, R., Balk, A., Bussmann, H. and 
Stam, H. (2004) Does aerobic training lead to a more ac-
tive lifestyle and improved quality of life in patients with 
chronic heart failure? European Journal of Heart Failure, 
6, 95-100. doi:10.1016/j.ejheart.2003.10.005 
[8] Oka, R.K., Stotts, N.A., Dae, M.W., et al. (1993) Daily 
physical activity levels in congestive heart failure. Ameri- 
can Journal of Cardiology, 71, 921-925. 
doi:10.1016/0002-9149(93)90907-T 
[9] Witham, M.D., Argo, I.S., Johnston, D.W., Struthers, A.D. 
and McMurdo, M.E.T. (2006) Predictors of exercise ca- 
pacity and everyday activity in older heart failure patients. 
European Journal of Heart Failure, 8, 203-207. 
doi:10.1016/j.ejheart.2005.03.008 
[10] Willenheimer, Rydberg, E., Cline, C., et al. (2001) Effects 
on quality of life symptoms, and daily activity 6 months 
after termination of an exercise programme in heart fail- 
ure patients. International Journal of Cardiology, 77, 25- 
31. doi:10.1016/S0167-5273(00)00383-1 
[11] Witham, M.D., Gray, J.M. and Argo, I.S. (2005) Effect of 
a seated exercise program to improve physical function 
and health status in frail patients > 70 years of age with 
heart failure. American Journal of Cardiology, 95, 1120- 
1124. doi:10.1016/j.amjcard.2005.01.031 
[12] Mueller, L., Myers, J., Kottman, W., et al. (2007) Exer- 
cise capacity, physical activity patterns and outcomes six 
years after cardiac rehabilitation in patients with heart 
failure. Clinical Rehabilitation, 21, 923-931. 
doi:10.1177/0269215507079097 
[13] Gottlieb, S.S., Fisher, M.L., Freudenberger, R., et al. 
(1999) Effects of exercise training on peak performance 
and quality of life in congestive heart failure patients. 
Journal of Cardiac Failure, 5, 188-194. 
doi:10.1016/S1071-9164(99)90002-7 
[14] Walsh, J.T., Andrews, R., Evans, A. and Cowley, A.J. 
(1995) Failure of “effective” treatment for heart failure to 
improve normal customary activity. British Heart Journal, 
73, 373-376. doi:10.1136/hrt.74.4.373 
[15] Walsh, J.T., Charlesworth, A., Andrews, R., Hawkins, M. 
and Cowley, A.J. (1997) Relation of daily activity levels 
in patients with chronic heart failure to long-term prog- 
nosis. American Journal of Cardiology, 79, 1364-1369. 
doi:10.1016/S0002-9149(97)00141-0 
[16] Howell, J., Strong, B.M., Weisenberg, J., et al. (2010) 
Maximum daily 6 minutes of activity: An index of funct- 
ional capacity derived from actigraphy and its appli- 
cation to older adults with heart failure. Journal of the 
American Geriatric Society, 58, 931-936. 
doi:10.1111/j.1532-5415.2010.02805.x 
[17] Allison, G.-C. (2009) Principal Scientist, Medtronic Cor-
poration.  
[18] Casburi, R. (2009) Activity monitoring in assessing ac- 
tivities of daily living. COPD, 4, 251-255. 
doi:10.1080/15412550701480158 
[19] Gulati, S.K., McKenzie, J., Crossley, G., Papp, M.A., 
Sims, J. and Andrulli, J. (2009) Device measured physical 
activity: Is it the new 6-minute hall walk? Journal of 
Cardiac Failure, 15, S119-120. 
doi:10.1016/j.cardfail.2009.06.055 
[20] Adamson, P.B., Smith, A.L., Abraham, W.T., et al. (2004) 
Continuous autonomic assessment in patients with symp-
tomatic heart failure: Prognostic value of heart rate vari-
ability measured by an implanted cardiac resynchroni- 
zation device. Circulation, 110, 2389-2394. 
doi:10.1161/01.CIR.0000139841.42454.78 
[21] Small, R.S., Wickemeyer, W., Germany, R., et al. (2009) 
Changes in intrathoracic impedance are associated with 
subsequent risk of hospitalizations for acute decompen- 
sated heart failure: Clinical utility of implanted device 
monitoring without a patient alert. Journal of Cardiac 
Failure, 15, 475-481. doi:10.1016/j.cardfail.2009.01.012 
[22] Jaeschke, R., Singer, J. and Guyatt, G.H. (1989) Measure 
of health status: Ascertaining the minimal clinically im-
portant difference. Controlled Clinical Trials, 10, 407- 
415. doi:10.1016/0197-2456(89)90005-6 
[23] Lydlick, E. and Epstein, R.S. (1993) Interpretation of 
Copyright © 2012 SciRes.                                                                                WJCD 
M. J. Shoemaker et al. / World Journal of Cardiovascular Diseases 2 (2012) 129-135 
Copyright © 2012 SciRes.                                                                                
135
WJCD 
quality of life measures. Quality of Life Research, 2, 221- 
226. doi:10.1007/BF00435226 
[24] Levy, W.C., Mozaffarian, D., Linker, D.T., et al. (2006) 
The Seattle Heart Failure Model: Prediction of survival in 
heart failure. Circulation, 113, 1424-1433. 
doi:10.1161/CIRCULATIONAHA.105.584102 
[25] Beaton, D.E., Boers, M. and Wells, G.A. (2002) Many 
faces of the minimal clinically important difference 
(MCID): A literature review and directions for future re- 
search. Current Opinion in Rheumatology, 14, 109-114. 
doi:10.1097/00002281-200203000-00006 
[26] HMISC: Harrell miscellaneous.  
http://cran.Rproject.Org/web/packages/hmisc/index.html 
[27] Gorodeski, E.A., Chu, E.C., Chow, C.H., et al. (2003) 
Application of the Seattle Heart Failure Model in ambu- 
latory patients presented to an advanced heart failure 
therapeutics committee. Circulation and Heart Failure, 3, 
706-714. 
doi:10.1161/CIRCHEARTFAILURE.110.944280 
[28] Russell, D.S., Saval, M.A., Robbins, J.L., et al. (2009) 
New York Heart Association functional class predicts ex-
ercise parameters in the current era. American Heart 
Journal, 158, S24-S30. doi:10.1016/j.ahj.2009.07.017 
[29] O’Keeffe, S.T., Lye, M., Donnellan, C. and Carmichael, 
D.N. (1998) Reproducibility and responsiveness of qua- 
lity of life assessment and six minute walk test in elderly 
heart failure patients. Heart, 80, 377-382. 
[30] Spertus, J., Peterson, E., Conard, M.W., et al. (2005) 
Monitoring clinical changes in patients with heart failure: 
A comparison of methods. American Heart Journal, 150, 
707-715. doi:10.1016/j.ahj.2004.12.010 
 
